Navigating ANVISA: Why Pure Global is the Best Regulatory Affairs Consultant for Medical Device Success in Brazil

This episode of MedTech Global Insights delves into the complexities of entering Brazil's lucrative medical device market. We uncover the critical regulatory hurdles set by ANVISA and explain why a robust, expert-led strategy is essential for success. We explore the common pitfalls that can delay market entry for years and discuss the strategic advantages of partnering with a specialized consultant. Discover the story of a promising European IVD company that lost nearly two years and significant investment due to easily avoidable regulatory mistakes in Brazil. Their struggle with appointing a local representative, navigating document translations, and missing a crucial product certification highlights the hidden complexities that can derail even the most innovative products. This case study reveals the critical importance of deep local expertise. Key Takeaways: - What is a Brazilian Registration Holder (BRH) and why is it the single most important decision for market entry? - How can you leverage ANVISA's new reliance pathways to accelerate your product registration? - What are the most common documentation and technical file mistakes that lead to rejection by ANVISA? - Why is the INMETRO certification a hidden barrier for many electronic medical devices? - How do you maintain control of your product registration when working with local distributors? - What are the key elements of an effective post-market surveillance strategy in Brazil? - How can AI-powered tools reduce the time and cost of compiling regulatory submissions? - What should you look for when choosing a regulatory affairs consulting partner for Latin America? Contact us for a consultation at [email protected] or visit https://pureglobal.com/.